BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29025906)

  • 1. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
    Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
    Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.
    Hrdinová J; Verbij FC; Kaijen PHP; Hartholt RB; van Alphen F; Lardy N; Ten Brinke A; Vanhoorelbeke K; Hindocha PJ; De Groot AS; Meijer AB; Voorberg J; Peyron I
    Haematologica; 2018 Jun; 103(6):1083-1092. PubMed ID: 29567779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
    van Haren SD; Wroblewska A; Herczenik E; Kaijen PH; Ruminska A; ten Brinke A; Meijer AB; Voorberg J
    PLoS One; 2013; 8(11):e80239. PubMed ID: 24244658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.
    van Haren SD; Herczenik E; ten Brinke A; Mertens K; Voorberg J; Meijer AB
    Mol Cell Proteomics; 2011 Jun; 10(6):M110.002246. PubMed ID: 21467215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products.
    Jankowski W; Park Y; McGill J; Maraskovsky E; Hofmann M; Diego VP; Luu BW; Howard TE; Kellerman R; Key NS; Sauna ZE
    Blood Adv; 2019 May; 3(9):1429-1440. PubMed ID: 31053570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hunting down factor VIII in the immunopeptidome.
    Hartholt RB; Peyron I; Voorberg J
    Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
    Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
    Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.
    Sorvillo N; Hartholt RB; Bloem E; Sedek M; ten Brinke A; van der Zwaan C; van Alphen FP; Meijer AB; Voorberg J
    Haematologica; 2016 Mar; 101(3):309-18. PubMed ID: 26635035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
    Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
    Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules.
    Mustafa AS; Shaban FA; Al-Attiyah R; Abal AT; El-Shamy AM; Andersen P; Oftung F
    Scand J Immunol; 2003 Feb; 57(2):125-34. PubMed ID: 12588658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.
    Hay CR; Ollier W; Pepper L; Cumming A; Keeney S; Goodeve AC; Colvin BT; Hill FG; Preston FE; Peake IR
    Thromb Haemost; 1997 Feb; 77(2):234-7. PubMed ID: 9157572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
    Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
    Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
    Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
    Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C
    J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein.
    Ruiter B; Rozemuller EH; van Dijk AJ; Garssen J; Bruijnzeel-Koomen CA; Tilanus MG; Knol EF; van Hoffen E
    Int Arch Allergy Immunol; 2007; 143(2):119-26. PubMed ID: 17228168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
    Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
    J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens.
    Nunez G; Ball EJ; Stastny P
    Hum Immunol; 1987 May; 19(1):29-39. PubMed ID: 3495523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.
    Gangadharan B; Ing M; Delignat S; Peyron I; Teyssandier M; Kaveri SV; Lacroix-Desmazes S
    Haematologica; 2017 Feb; 102(2):271-281. PubMed ID: 27758819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer.
    Gjertsen HA; Lundin KE; Sollid LM; Eriksen JA; Thorsby E
    Hum Immunol; 1994 Apr; 39(4):243-52. PubMed ID: 7520895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.